Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,685,742
-
Share change
-
+1,481,040
-
Total reported value
-
$131,891,710
-
Price per share
-
$10.35
-
Number of holders
-
63
-
Value change
-
+$15,539,681
-
Number of buys
-
33
-
Number of sells
-
27
Institutional Holders of IMMUNE DESIGN CORP - COM (IMDZ) as of Q3 2017
As of 30 Sep 2017,
IMMUNE DESIGN CORP - COM (IMDZ) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,685,742 shares.
The largest 10 holders included
Versant Venture Management, LLC, VICTORY CAPITAL MANAGEMENT INC, Bain Capital Public Equity Management, LLC, BlackRock Inc., FRANKLIN RESOURCES INC, DOHENY ASSET MANAGEMENT /CA, VANGUARD GROUP INC, JPMORGAN CHASE & CO, FMR LLC, and Abingworth LLP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.